{"id":"https://openalex.org/W4367603872","doi":"https://doi.org/10.1158/2643-3249.aml23-ia11","title":"Abstract IA11: Targeting IDH-mutant myeloid leukemia by disabling metabolic dependencies","display_name":"Abstract IA11: Targeting IDH-mutant myeloid leukemia by disabling metabolic dependencies","publication_year":2023,"publication_date":"2023-05-01","ids":{"openalex":"https://openalex.org/W4367603872","doi":"https://doi.org/10.1158/2643-3249.aml23-ia11"},"language":"en","primary_location":{"id":"doi:10.1158/2643-3249.aml23-ia11","doi":"https://doi.org/10.1158/2643-3249.aml23-ia11","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/2643-3249.aml23-ia11","pdf_url":null,"source":{"id":"https://openalex.org/S4210239195","display_name":"Blood Cancer Discovery","issn_l":"2643-3230","issn":["2643-3230","2643-3249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Cancer Discovery","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088119941","display_name":"Jian Xu","orcid":"https://orcid.org/0000-0003-1988-7337","observed_orcids":["https://orcid.org/0000-0003-1988-7337"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jian Xu","raw_affiliation_strings":["1UT Southwestern Medical Center, DALLAS, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Southwestern Medical Center, DALLAS, TX","institution_ids":["https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5088119941"],"corresponding_institution_ids":["https://openalex.org/I867280407"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"3_Supplement","first_page":"IA11","last_page":"IA11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idh1-mutation","display_name":"IDH1 mutation","score":0.753000020980835},{"id":"https://openalex.org/keywords/idh2-mutation","display_name":"IDH2 mutation","score":1.0},{"id":"https://openalex.org/keywords/2-hydroxyglutarate","display_name":"2-hydroxyglutarate","score":0.9309999942779541},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.7649999856948853},{"id":"https://openalex.org/keywords/second-site-mutations","display_name":"second-site mutations","score":0.9710000157356262},{"id":"https://openalex.org/keywords/nadph-binding-site","display_name":"NADPH binding site","score":0.8149999976158142},{"id":"https://openalex.org/keywords/cd44","display_name":"CD44","score":0.8529999852180481},{"id":"https://openalex.org/keywords/cell-adhesion-molecules","display_name":"adhesion molecules","score":0.6980000138282776},{"id":"https://openalex.org/keywords/metabolic-dependencies","display_name":"metabolic dependencies","score":0.5360000133514404},{"id":"https://openalex.org/keywords/crispr-base-editing","display_name":"CRISPR base editing","score":0.9330000281333923},{"id":"https://openalex.org/keywords/epigenetic-dysregulation","display_name":"epigenetic dysregulation","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C2776059313","wikidata":"https://www.wikidata.org/wiki/Q21116031","display_name":"IDH2","level":5,"score":0.6498796343803406},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6145968437194824},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5953457355499268},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5360738635063171},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.48885577917099},{"id":"https://openalex.org/C127848430","wikidata":"https://www.wikidata.org/wiki/Q18027543","display_name":"IDH1","level":4,"score":0.42060238122940063},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3389657139778137},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.26181209087371826}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2643-3249.aml23-ia11","doi":"https://doi.org/10.1158/2643-3249.aml23-ia11","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/2643-3249.aml23-ia11","pdf_url":null,"source":{"id":"https://openalex.org/S4210239195","display_name":"Blood Cancer Discovery","issn_l":"2643-3230","issn":["2643-3230","2643-3249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Cancer Discovery","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4304695241","https://openalex.org/W3096651198","https://openalex.org/W4310106120","https://openalex.org/W2765390373","https://openalex.org/W4409899844","https://openalex.org/W3169009716","https://openalex.org/W3087271900","https://openalex.org/W3197827905","https://openalex.org/W2566986989","https://openalex.org/W2810336146"],"abstract_inverted_index":{"Abstract":[0],"Somatic":[1],"mutations":[2,110,153,173,184],"in":[3,193,208,217,275,278],"catalytic":[4],"arginine":[5],"residues":[6],"of":[7,15,23,39,48,56,69,84,107,120,128,139,161,170,201,211,229,243,273,297,308,330],"IDH1":[8,149],"and":[9,45,63,81,131,213,221,226,257,268,277,310,338],"IDH2":[10,151],"contribute":[11],"to":[12,86,96,197,264],"the":[13,21,24,54,66,77,82,105,118,126,146,199,209,240,331],"pathogenesis":[14],"acute":[16],"myeloid":[17,141,313,321],"leukemia":[18,142,260,299,322],"(AML)":[19],"through":[20,101,178],"production":[22,44,207],"oncometabolite":[25],"(R)-2-hydroxyglutarate":[26],"(R-2-HG).":[27],"Accumulating":[28],"R-2HG":[29,43,206],"causes":[30],"epigenetic":[31],"alterations":[32],"by":[33,154,224,323],"impairing":[34],"\u03b1KG-dependent":[35],"dioxygenases.":[36],"Allosteric":[37],"inhibitors":[38,88],"mutant":[40,250],"IDH":[41,97,162,171,190,266],"suppress":[42],"induce":[46],"differentiation":[47],"leukemic":[49],"blasts.":[50],"These":[51,115],"findings":[52,116,283],"provide":[53],"basis":[55],"two":[57],"targeted":[58],"therapies":[59],"for":[60,125,175,249,304],"AML":[61,132,219],"(ivosidenib":[62],"enasidenib),":[64],"establishing":[65],"first":[67],"example":[68],"personalized":[70],"therapy":[71,94,176,215],"based":[72],"on":[73],"cancer":[74],"metabolism.":[75],"However,":[76],"low":[78],"response":[79],"rate":[80],"development":[83],"resistance":[85,95,177,216],"IDHmut":[87],"are":[89,262],"major":[90],"clinical":[91],"challenges.":[92],"Moreover,":[93,223],"inhibition":[98,267],"can":[99],"occur":[100],"multiple":[102],"mechanisms,":[103],"including":[104],"selection":[106],"R-2HG-restoring":[108],"second-site":[109,172],"or":[111,150,195,270],"other":[112],"sub-clonal":[113],"mutations.":[114],"underscore":[117],"importance":[119],"developing":[121],"more":[122,305],"effective":[123,306],"approaches":[124],"treatment":[127,307],"IDH-mutant":[129,218,259,298,312,320],"MDS":[130],"patients.":[133,222],"Here":[134],"we":[135,166,233],"developed":[136],"a":[137,168,235,285,293],"panel":[138],"isogenic":[140,231],"cell":[143,286],"lines":[144],"containing":[145],"most":[147],"common":[148],"oncogenic":[152],"CRISPR":[155],"base":[156],"editing.":[157],"By":[158],"saturation":[159],"mutagenesis":[160],"single-amino":[163],"acid":[164],"variants,":[165],"identified":[167,234],"repertoire":[169],"responsible":[174],"disabling":[179,324],"uncompetitive":[180],"enzyme":[181],"inhibition.":[182],"Recurrent":[183],"at":[185],"NADPH":[186],"binding":[187],"sites":[188],"within":[189],"heterodimers":[191],"act":[192],"cis":[194],"trans":[196],"prevent":[198],"formation":[200],"stable":[202],"enzyme-inhibitor":[203],"complexes,":[204],"restore":[205],"presence":[210],"inhibitors,":[212],"drive":[214],"cells":[220,261],"transcriptomic":[225],"epigenomic":[227],"profiling":[228],"base-edited":[230],"cells,":[232,300],"new":[236,294],"regulatory":[237],"axis":[238],"involving":[239],"CD44-mediated":[241],"rewiring":[242],"intracellular":[244],"metabolism,":[245],"which":[246],"is":[247],"required":[248],"IDH-catalyzed":[251],"R-2-HG":[252],"production.":[253],"More":[254],"importantly,":[255],"primary":[256,309],"resistant":[258,311],"sensitive":[263],"combined":[265],"genetic":[269],"pharmacologic":[271],"inactivation":[272],"CD44":[274],"vitro":[276],"vivo.":[279],"Taken":[280],"together,":[281],"our":[282],"uncover":[284],"adhesion":[287],"molecule-mediated":[288],"metabolic":[289,325],"signaling":[290],"pathway":[291],"as":[292],"targetable":[295],"dependency":[296],"with":[301],"therapeutic":[302],"implications":[303],"malignancies.":[314],"Citation":[315],"Format:":[316],"Jian":[317],"Xu.":[318],"Targeting":[319],"dependencies":[326],"[abstract].":[327],"In:":[328],"Proceedings":[329],"AACR":[332],"Special":[333],"Conference:":[334],"Acute":[335],"Myeloid":[336],"Leukemia":[337],"Myelodysplastic":[339],"Syndrome;":[340],"2023":[341],"Jan":[342],"23-25;":[343],"Austin,":[344],"TX.":[345],"Philadelphia":[346],"(PA):":[347],"AACR;":[348],"Blood":[349],"Cancer":[350],"Discov":[351],"2023;4(3_Suppl):Abstract":[352],"nr":[353],"IA11.":[354]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2023-05-02T00:00:00"}